169 related articles for article (PubMed ID: 34516357)
1. Integrated weighted gene co-expression network analysis uncovers STAT1(signal transducer and activator of transcription 1) and IFI44L (interferon-induced protein 44-like) as key genes in pulmonary arterial hypertension.
Yang H; Lu Y; Yang H; Zhu Y; Tang Y; Li L; Liu C; Yuan J
Bioengineered; 2021 Dec; 12(1):6021-6034. PubMed ID: 34516357
[TBL] [Abstract][Full Text] [Related]
2. Bioinformatics analysis of the immune cell infiltration characteristics and correlation with crucial diagnostic markers in pulmonary arterial hypertension.
Lian G; You J; Lin W; Gao G; Xu C; Wang H; Luo L
BMC Pulm Med; 2023 Aug; 23(1):300. PubMed ID: 37582718
[TBL] [Abstract][Full Text] [Related]
3. The identification and verification of hub genes associated with pulmonary arterial hypertension using weighted gene co-expression network analysis.
Wu W; Chen A; Lin S; Wang Q; Lian G; Luo L; Xie L
BMC Pulm Med; 2022 Dec; 22(1):474. PubMed ID: 36514015
[TBL] [Abstract][Full Text] [Related]
4. Exploration of the Shared Gene Signatures and Molecular Mechanisms Between Systemic Lupus Erythematosus and Pulmonary Arterial Hypertension: Evidence From Transcriptome Data.
Yao M; Zhang C; Gao C; Wang Q; Dai M; Yue R; Sun W; Liang W; Zheng Z
Front Immunol; 2021; 12():658341. PubMed ID: 34335565
[TBL] [Abstract][Full Text] [Related]
5. Weighted gene co-expression network analysis identifies dysregulated B-cell receptor signaling pathway and novel genes in pulmonary arterial hypertension.
Chen Y; Wu C; Wang X; Zhou X; Kang K; Cao Z; Yang Y; Zhong Y; Xiao G
Front Cardiovasc Med; 2022; 9():909399. PubMed ID: 36277750
[TBL] [Abstract][Full Text] [Related]
6. Identifying Potential Mitochondrial Proteome Signatures Associated with the Pathogenesis of Pulmonary Arterial Hypertension in the Rat Model.
Wang J; Uddin MN; Li Q; Aierken A; Li MY; Wang R; Yan QZ; Adi D; Gai MT; Wu Y
Oxid Med Cell Longev; 2022; 2022():8401924. PubMed ID: 35237384
[TBL] [Abstract][Full Text] [Related]
7. RGS5 as a Biomarker of Pericytes, Involvement in Vascular Remodeling and Pulmonary Arterial Hypertension.
Lu G; Du R; Liu Y; Zhang S; Li J; Pei J
Vasc Health Risk Manag; 2023; 19():673-688. PubMed ID: 37881333
[TBL] [Abstract][Full Text] [Related]
8. Integrative analyses of gene expression profile reveal potential crucial roles of mitotic cell cycle and microtubule cytoskeleton in pulmonary artery hypertension.
Luo J; Li H; Liu Z; Li C; Wang R; Fang J; Lu S; Guo J; Zhu X; Wang X
BMC Med Genomics; 2020 Jun; 13(1):86. PubMed ID: 32586319
[TBL] [Abstract][Full Text] [Related]
9. Identification of novel biomarkers involved in pulmonary arterial hypertension based on multiple-microarray analysis.
Ma Y; Chen SS; Feng YY; Wang HL
Biosci Rep; 2020 Sep; 40(9):. PubMed ID: 32886110
[TBL] [Abstract][Full Text] [Related]
10. Bioinformatic exploration of the immune related molecular mechanism underlying pulmonary arterial hypertension.
Huang R; Zheng X; Wang J
Bioengineered; 2021 Dec; 12(1):3137-3147. PubMed ID: 34252346
[TBL] [Abstract][Full Text] [Related]
11. Transcriptomic Analysis of Right Ventricular Remodeling in Two Rat Models of Pulmonary Hypertension: Identification and Validation of Epithelial-to-Mesenchymal Transition in Human Right Ventricular Failure.
Park JF; Clark VR; Banerjee S; Hong J; Razee A; Williams T; Fishbein G; Saddic L; Umar S
Circ Heart Fail; 2021 Feb; 14(2):e007058. PubMed ID: 33541093
[TBL] [Abstract][Full Text] [Related]
12. PARM1 Drives Smooth Muscle Cell Proliferation in Pulmonary Arterial Hypertension via AKT/FOXO3A Axis.
He Z; Chang T; Chen Y; Wang H; Dai L; Zeng H
Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047359
[TBL] [Abstract][Full Text] [Related]
13. Identification of ACKR4 as an immune checkpoint in pulmonary arterial hypertension.
Jiang CY; Wu LW; Liu YW; Feng B; Ye LC; Huang X; He YY; Shen Y; Zhu YF; Zhou XL; Jiang DJ; Qi HK; Zhang H; Yan Y
Front Immunol; 2023; 14():1153573. PubMed ID: 37449198
[TBL] [Abstract][Full Text] [Related]
14. Combination Therapy with STAT3 Inhibitor Enhances SERCA2a-Induced BMPR2 Expression and Inhibits Pulmonary Arterial Hypertension.
Bisserier M; Katz MG; Bueno-Beti C; Brojakowska A; Zhang S; Gubara S; Kohlbrenner E; Fazal S; Fargnoli A; Dorfmuller P; Humbert M; Hata A; Goukassian DA; Sassi Y; Hadri L
Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502015
[TBL] [Abstract][Full Text] [Related]
15. Integrated bioinformatic analysis reveals the underlying molecular mechanism of and potential drugs for pulmonary arterial hypertension.
Dong H; Li X; Cai M; Zhang C; Mao W; Wang Y; Xu Q; Chen M; Wang L; Huang X
Aging (Albany NY); 2021 May; 13(10):14234-14257. PubMed ID: 34016786
[TBL] [Abstract][Full Text] [Related]
16. Integrated Bioinformatics Analysis Reveals Marker Genes and Potential Therapeutic Targets for Pulmonary Arterial Hypertension.
Li A; He J; Zhang Z; Jiang S; Gao Y; Pan Y; Wang H; Zhuang L
Genes (Basel); 2021 Aug; 12(9):. PubMed ID: 34573320
[TBL] [Abstract][Full Text] [Related]
17. IFI44L as a novel epigenetic silencing tumor suppressor promotes apoptosis through JAK/STAT1 pathway during lung carcinogenesis.
Zeng Y; Chen HQ; Zhang Z; Fan J; Li JZ; Zhou SM; Wang N; Yan SP; Cao J; Liu JY; Zhou ZY; Liu WB
Environ Pollut; 2023 Feb; 319():120943. PubMed ID: 36584854
[TBL] [Abstract][Full Text] [Related]
18. Identification of differentially expressed ER stress-related genes and their association with pulmonary arterial hypertension.
Yang Q; Lai B; Xie H; Deng M; Li J; Yang Y; Wan J; Liao B; Liu F
Respir Res; 2024 May; 25(1):220. PubMed ID: 38789967
[TBL] [Abstract][Full Text] [Related]
19. Identification of biomarkers related to copper metabolism in patients with pulmonary arterial hypertension.
Wang L; Zhang W; Li C; Chen X; Huang J
BMC Pulm Med; 2023 Jan; 23(1):31. PubMed ID: 36690956
[TBL] [Abstract][Full Text] [Related]
20.
Bai Z; Xu L; Dai Y; Yuan Q; Zhou Z
J Thorac Dis; 2021 Apr; 13(4):2242-2254. PubMed ID: 34012575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
